期刊文献+

临床检验学中急性脑梗死患者的超敏C反应蛋白、同型半胱氨酸及脂蛋白a联合检测变化研究 被引量:6

Research of changes in combined detection of high-sensitivity C-reactive protein,homocysteine and lipoprotein a for acute cerebral infarction patients in clinical laboratory
下载PDF
导出
摘要 目的探讨超敏C反应蛋白(hs-CRP)、同型半胱氨酸(Hcy)及脂蛋白a[LP(a)]与急性脑梗死的关系。方法检测68例脑梗死患者(急性脑梗死组)和100例健康人(健康对照组)血清超敏C反应蛋白、同型半胱氨酸及脂蛋白a的含量。结果急性脑梗死组超敏C反应蛋白、同型半胱氨酸、脂蛋白a含量[(11.28±5.17)mg/g、(19.1±4.7)μmol/L、(468±147)mg/g]明显高于健康对照组[(2.31±1.15)mg/g、(8.32±2.1)μmol/L、(196±81)mg/g](P<0.01)。结论超敏C反应蛋白、同型半胱氨酸、脂蛋白a与急性脑梗死的发生有关,三者同时检测对急性脑梗死的早期诊断疗效观察,预后判断具有重要的临床意义。 Objective To investigate relationship between high-sensitivity C-reactive protein (hs-CRP), homocysteine (Hcy), lipoprotein a[LP(a)]and acute cerebral infarction. Methods Detections of serum high-sensitivity C-reactive protein, homocysteine and lipoprotein a contents were made in 68 acute cerebral infarction patients (acute cerebral infarction group) and 100 healthy people (healthy control group). Results The acute cerebral infarction group had all much higher high-sensitivity C-reactive protein, homocysteine and lipoprotein a contents[(11.28±5.17)mg/g, (19.1±4.7)μmol/L, (468±147)mg/g]than the healthy control group[(2.31±1.15)mg/g, (8.32±2.1)μmol/L, (196±81)mg/g](P〈0.01). Conclusion High-sensitivity C-reactive protein, homocysteine and lipoprotein a are related with occurrence of acute cerebral infarction. Combined detection of the three indexes contains important clinical significance for early diagnosis, curative effect observation and prognosis judgment in acute cerebral infarction.
作者 苏红阁 艾冉
出处 《中国实用医药》 2016年第23期16-17,共2页 China Practical Medicine
关键词 急性脑梗死 超敏C反应蛋白 同型半胱氨酸 脂蛋白A Acute cerebral infarction High-sensitivity C-reactive protein Homocysteine Lipoprotein a
  • 相关文献

参考文献3

二级参考文献20

  • 1[1]Guba SC,Fink LM,Fonseca V. Hyperhomocysteinemia:An emerging and important risk factor for thromboembolic and cardiovascular disease[J]. Am J Clin Pathol., 1996,106(6):709-722
  • 2[2]Mudd SH, Skovby F, Levy HL. Disorders of transsulfuration. In:Scriver CR, et al.,eds. The metabolic and molecular bases of inherited disease[M]. 7th ed. Vol. New York: McGraw-Hill, 1995.1279-1327.
  • 3[3]Jacob RA,Wu MM, Henning SM, et al. Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction[J]. J Nutr, 1994,124(7): 1072-1080.
  • 4[4]Hoogeveen EK, Kostense PJ, Beks PJ, et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in noninsulin-dependent diabetes mellitus:a population-based study [J].Arterioscler Thromb Vasc Biol,1998,18(1):133-138.
  • 5[5]Stern JM, Saver JL, Boldy RM,et al. Homocysteine associated hypercoagulability and disseminated thrombosis a case report[J]. Angiology, 1998,49(9):765-769.
  • 6[6]Frantzen F, Faaren AL, Alfheim I, et al. Enzyme conversion immunoassay for determining total homocysteine in plasma or serum[J]. Clin Chem, 1998,44(2):311-316.
  • 7[7]Durand P, Fortin LJ,Lussier-Cacans, et al. Hyperhomocysteinemia induced by folic acid deficiency and methionine load-applications of modified HPLC method[J]. Clin Chim Acta, 1996, 252(1):83-93.
  • 8[9]Pfeiffer CM, Twite D, Shih J, et al. Method comparison for total plasma homocysteine between the Abbott IMx analyzer and an HPLC assay with internal standardization[J].Clin Chem, 1999,45(1):152-153.
  • 9[11]McCully KS. Homocysteine and vascular disease[J]. Nat Med, 1996,2:386-389.
  • 10[12]Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease[J]. JAMA, 1995,274(13): 1049-1057.

共引文献33041

同被引文献56

引证文献6

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部